Trial to Evaluate Efficacy and Safety of Apraglutide in SBS-IF
Status:
Recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
The primary objective of the trial is the confirmation of the efficacy of apraglutide to
evaluate the efficacy of weekly subcutaneous apraglutide in reducing parenteral support
dependency.